B S Kramer

发表

Molecular and genetic targets in early detection.

B. Kramer, D. Henson, S. Srivastava, 1999, Current opinion in oncology.

Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).

S. Steinberg, B. Kramer, A. Gazdar, 1989, Cancer research.

The role of increasing detection in the rising incidence of prostate cancer.

B A Miller, P C Albertsen, B. Kramer, 1995, JAMA.

Prostate Cancer Screening: What We Know and What We Need To Know

P C Prorok, P. Prorok, A. Potosky, 1993, Annals of Internal Medicine.

Grappling with cancer--defeatism versus the reality of progress.

B. Kramer, B S Kramer, R D Klausner, 1997, The New England journal of medicine.

A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers

P C Prorok, P. Prorok, B. Kramer, 2010, Cancer.

Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay.

S. Steinberg, B. Kramer, J. Minna, 1987, Cancer research.

Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.

P C Prorok, J. Gohagan, P. Prorok, 1994, The Journal of urology.

NIH Consensus 1994: screening.

P C Prorok, J. Gohagan, P. Prorok, 1994, Gynecologic oncology.

Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies.

S G Baker, B. Kramer, S. Baker, 2001, Journal of women's health & gender-based medicine.